DuPont De Nemours (DD) Could Be 20% Below Fair Value After Recent Pullback
E. I. du Pont de Nemours and Company DD | 0.00 |
DuPont de Nemours (DD) is back in focus after recent trading data highlighted its mixed return profile, with the stock down over the past month and past 3 months but higher year to date.
At the latest share price of $137.0, DuPont de Nemours has seen short term share price momentum cool. However, its 11.74% year to date share price return and 59.00% 1 year total shareholder return point to a stronger longer term picture.
If you are comparing DuPont de Nemours with other opportunities, this could be a good moment to widen your search and review the 35 power grid technology and infrastructure stocks
After DuPont de Nemours cooled off in the short term, the current $137.0 share price now sits well below a range of external value markers. How far does fair value really differ from where the stock trades today?
Most Popular Narrative: 20.4% Undervalued
On the most followed narrative, DuPont de Nemours screens as undervalued, with a fair value of $172.07 set against the current $137.00 share price.
The company's renewed portfolio focus post Qnity spin and recent divestitures in non core segments enables greater resource allocation to high growth specialty businesses, contributing to improved operating margin and increased earnings stability. DuPont's robust innovation pipeline, including content and share gains in advanced nodes and the water tech portfolio, underpins premium pricing opportunities and sustainably enhances gross margins over the medium to long term.
Want to understand why this narrative supports a much higher fair value for DuPont de Nemours? It examines expectations for top line expansion, potential margin improvements, and a richer future earnings multiple than today. The full breakdown explains how those elements fit together.
Result: Fair Value of $172.07 (UNDERVALUED)
However, DuPont de Nemours still faces meaningful risks, including ongoing PFAS related legal exposure and revenue pressure if pricing remains weak in diversified industrials.
Another View on DuPont de Nemours Valuation
The earlier fair value narrative for DuPont de Nemours leans on forward earnings and growth assumptions. Yet on today's figures the stock trades at a P/E of 140.1x, which is very high compared with the US Chemicals industry at 25.6x, the peer average at 21.1x, and a fair ratio of 29.2x. That gap points to meaningful valuation risk if expectations shift.
To see how this richer P/E picture fits with the rest of the numbers, and where the ratio might move over time, See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed signals around DuPont de Nemours can be confusing at first glance, so move quickly to review the key numbers and form your own judgement with the 4 key rewards and 2 important warning signs
Looking for more investment ideas beyond DuPont de Nemours?
If you only stop at DuPont de Nemours today, you could miss other stocks that better fit your goals, risk comfort, and income needs across the market.
- Target long term compounders by scanning for companies that look attractively priced on fundamentals using the 55 high quality undervalued stocks.
- Strengthen your income stream by focusing on reliable payers through the 9 dividend fortresses.
- Keep risk in check by concentrating on companies with healthier financial foundations via the solid balance sheet and fundamentals stocks screener (45 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
